Nu Skin Enterprises, Inc.

NUS ·Healthcare, Medical Distribution, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $320.1M $320.6M $370.3M $364.2M $386.1M $364.5M $445.6M $430.1M
Cost of Revenue $101.8M $106.1M $108.3M $107.5M $120.4M $117.5M $166.4M $128.7M
Gross Profit $218.3M $214.5M $262.0M $256.7M $265.7M $247.0M $279.1M $301.5M
Gross Margin 68.2% 66.9% 70.7% 70.5% 68.8% 67.8% 62.7% 70.1%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $90.8M $98.5M $107.4M $104.8M $106.7M $113.2M $120.9M $115.6M
Operating Income $-59.3M $4.0M $23.2M $21.6M $30.8M $-9.9M $-53.1M $18.2M
Operating Margin -18.5% 1.3% 6.3% 5.9% 8.0% -2.7% -11.9% 4.2%
Interest Expense — — — — — — — $6.5M
Pretax Income $-63.2M $2.6M $18.2M $16.0M $27.4M $134.6M $-57.8M $13.3M
Income Tax Expense $186.6M $763.0K $3.7M $-1.1M $6.3M $27.1M $-21.7M $5.0M
Net Income $-249.8M $1.8M $14.5M $17.1M $21.1M $107.5M $-36.1M $8.3M
Net Margin -78.0% 0.6% 3.9% 4.7% 5.5% 29.5% -8.1% 1.9%
EPS (Basic) $-5.14 $0.04 $0.31 $0.35 $0.43 $2.16 $-0.73 $0.17
EPS (Diluted) $-5.14 $0.04 $0.27 $0.34 $0.43 $2.14 $-0.73 $0.17
Shares Outstanding (Basic) 48.6M 48.2M 49.3M 49.4M 49.4M 49.8M 49.7M 49.7M
Shares Outstanding (Diluted) 48.6M 49.4M 50.3M 50.3M 49.5M 50.3M 49.7M 49.7M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 6 Older →